I think some patience is required @ragingboom. Just because things aren't happening as fast as you would like them to doesn't mean management are doing a poor job. Pre-development stage projects are renowned for being slow in terms of information flow. The next major announcement for mine is the revised feasibility study numbers. This will give us a better idea of the commercial viability of the project. In addition to this would be off take agreements associated with the 5000 ton samples.
The time this is going to take also potentially opens the door for a takeover offer. One possible candidate is a company I presently invest in called Fertoz (ASX:FTZ). These guys have a growing organic fertiliser business and are presently sourcing all their phosphate from deposits they own in North America. They have an Asian Pacific business segment as well in which I feel Ardmore could fit into perfectly. The scale is right and more importantly the longer this drags out, the price is right.
There are a number of potential catalysts in play for this company but your time frame is probably going to have to shift from hours, days and weeks to perhaps 6-12 months at least. In my opinion you are doing this thread and the company no favours with your continuous bitching and moaning not to mention those announcement predictions.
Let's wait and see how it plays out. The share price will move when "its" good and ready. If the direction is down in the near term so be it.
- Forums
- ASX - By Stock
- CXM
- General discussion
CXM
centrex limited
Add to My Watchlist
0.00%
!
1.7¢

General discussion, page-162
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.74M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CXM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online